Tu1761 DEVELOPMENT OF A MOTILITY FRAILTY INDEX IN PATIENTS WITH GASTROINTESTINAL MOTILITY SYMPTOMS

2020 ◽  
Vol 158 (6) ◽  
pp. S-1149-S-1150
Author(s):  
Jared T. Winston ◽  
Patricia Guzman Rojas ◽  
Abigail Stocker ◽  
Douglas Lorenz ◽  
Michael W. Daniels ◽  
...  
1955 ◽  
Vol 29 (5) ◽  
pp. 789-802 ◽  
Author(s):  
John T. Farrar ◽  
Franz J. Ingelfinger

1951 ◽  
Vol 17 (4) ◽  
pp. 551-559 ◽  
Author(s):  
Michael J. Lepore ◽  
Ross Golden ◽  
Charles A. Flood

1955 ◽  
Vol 28 (4) ◽  
pp. 500-509 ◽  
Author(s):  
William P. Chapman ◽  
Stanley M. Wyman ◽  
Jacques O. Gagnon ◽  
John A. Benson ◽  
Chester M. Jones ◽  
...  

2013 ◽  
Vol 63 (1) ◽  
pp. 93-94
Author(s):  
Tetsuro Oono

2019 ◽  
Vol 20 (6) ◽  
pp. 614-629 ◽  
Author(s):  
Eglantina Idrizaj ◽  
Rachele Garella ◽  
Roberta Squecco ◽  
Maria Caterina Baccari

The present review focuses on adipocytes-released peptides known to be involved in the control of gastrointestinal motility, acting both centrally and peripherally. Thus, four peptides have been taken into account: leptin, adiponectin, nesfatin-1, and apelin. The discussion of the related physiological or pathophysiological roles, based on the most recent findings, is intended to underlie the close interactions among adipose tissue, central nervous system, and gastrointestinal tract. The better understanding of this complex network, as gastrointestinal motor responses represent peripheral signals involved in the regulation of food intake through the gut-brain axis, may also furnish a cue for the development of either novel therapeutic approaches in the treatment of obesity and eating disorders or potential diagnostic tools.


Sign in / Sign up

Export Citation Format

Share Document